2 selected, source-linked Plecanatide records carrying a 2018 source date. This is a navigational view of PeptideScanner’s selected coverage—not a complete research timeline or a statement about safety or effectiveness.
The Federal Register published notice 2018-26289, attributed to FDA and its parent HHS department, on 2018-12-04. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; TRULANCE,” and PeptideScanner's exact reviewed identity mapping connects the document to Plecanatide.
The Federal Register published notice 2018-25950, attributed to FDA and its parent HHS department, on 2018-11-29. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Plecanatide.